US Stock MarketDetailed Quotes

Alpha Tau Medical (DRTS)

Watchlist
  • 7.120
  • -0.560-7.29%
Close Jan 16 16:00 ET
  • 7.290
  • +0.170+2.39%
Post 17:51 ET
607.08MMarket Cap-13.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alpha Tau Medical (DRTS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
29.43%10.73M
6.56%9.65M
10.49%9.31M
1.01%36.04M
3.33%10.27M
-7.11%8.29M
10.85%9.05M
-2.55%8.42M
11.03%35.68M
24.52%9.94M
Selling and administrative expenses
14.45%2.42M
20.48%2.64M
8.20%2.14M
-2.53%9.02M
11.74%2.74M
-5.99%2.12M
-1.13%2.19M
-15.48%1.98M
-17.70%9.26M
-5.83%2.45M
-Selling and marketing expense
-7.37%490K
-23.50%459K
-13.88%459K
22.09%2.35M
51.99%687K
-4.17%529K
15.38%600K
33.25%533K
97.54%1.92M
13.85%452K
-General and administrative expense
21.73%1.93M
37.09%2.18M
16.35%1.68M
-8.99%6.67M
2.65%2.05M
-6.59%1.59M
-6.20%1.59M
-25.54%1.44M
-28.62%7.33M
-9.38%2M
Research and development costs
34.57%8.31M
2.13%7.01M
11.20%7.17M
2.26%27.02M
0.57%7.53M
-7.49%6.17M
15.30%6.87M
2.25%6.45M
26.49%26.42M
39.22%7.49M
Operating profit
-29.43%-10.73M
-6.56%-9.65M
-10.49%-9.31M
-1.01%-36.04M
-3.33%-10.27M
7.11%-8.29M
-10.85%-9.05M
2.55%-8.42M
-11.03%-35.68M
-24.52%-9.94M
Net non-operating interest income expense
-272.57%-2.31M
-44.99%944K
61.26%716K
-16.60%3.93M
-42.99%435K
-34.09%1.34M
18.75%1.72M
-7.11%444K
166.59%4.72M
-90.42%763K
Non-operating interest income
----
----
----
-11.45%4.28M
----
----
----
----
169.83%4.83M
----
Non-operating interest expense
----
----
----
304.00%303K
----
----
----
----
--75K
----
Total other finance cost
117.57%617K
63.68%748K
-61.26%-716K
5.13%41K
-11.35%3.54M
11.43%-3.51M
-6.54%457K
7.11%-444K
85.71%39K
164.63%3.99M
Other net income (expense)
-79.98%365K
154.01%1.82M
Gain on sale of security
----
----
----
-79.98%365K
----
----
----
----
154.01%1.82M
----
Income before tax
-68.89%-11.69M
-36.42%-10.05M
-7.67%-8.59M
-8.93%-31.74M
-28.78%-9.47M
-39.85%-6.92M
15.01%-7.37M
2.28%-7.98M
13.64%-29.14M
-116.83%-7.36M
Income tax
-8K
2,066.67%65K
9,800.00%99K
-62.50%6K
-75.00%2K
0
-88.46%3K
-95.24%1K
-20.00%16K
166.67%8K
Net income
-68.78%-11.69M
-37.25%-10.11M
-8.90%-8.69M
-8.89%-31.75M
-28.66%-9.48M
-40.96%-6.92M
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
Net income continuous Operations
-68.78%-11.69M
-37.25%-10.11M
-8.90%-8.69M
-8.89%-31.75M
-28.66%-9.48M
-40.96%-6.92M
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
Minority interest income
Net income attributable to the parent company
-68.78%-11.69M
-37.25%-10.11M
-8.90%-8.69M
-8.89%-31.75M
-28.66%-9.48M
-40.96%-6.92M
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-68.78%-11.69M
-37.25%-10.11M
-8.90%-8.69M
-8.89%-31.75M
-28.66%-9.48M
-40.96%-6.92M
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
Basic earnings per share
-40.00%-0.14
-18.18%-0.13
-9.09%-0.12
-7.14%-0.45
-18.18%-0.13
-42.86%-0.1
8.33%-0.11
8.33%-0.11
20.75%-0.42
-175.00%-0.11
Diluted earnings per share
-40.00%-0.14
-18.18%-0.13
-9.09%-0.12
-7.14%-0.45
-18.18%-0.13
-42.86%-0.1
8.33%-0.11
8.33%-0.11
20.75%-0.42
-175.00%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 29.43%10.73M6.56%9.65M10.49%9.31M1.01%36.04M3.33%10.27M-7.11%8.29M10.85%9.05M-2.55%8.42M11.03%35.68M24.52%9.94M
Selling and administrative expenses 14.45%2.42M20.48%2.64M8.20%2.14M-2.53%9.02M11.74%2.74M-5.99%2.12M-1.13%2.19M-15.48%1.98M-17.70%9.26M-5.83%2.45M
-Selling and marketing expense -7.37%490K-23.50%459K-13.88%459K22.09%2.35M51.99%687K-4.17%529K15.38%600K33.25%533K97.54%1.92M13.85%452K
-General and administrative expense 21.73%1.93M37.09%2.18M16.35%1.68M-8.99%6.67M2.65%2.05M-6.59%1.59M-6.20%1.59M-25.54%1.44M-28.62%7.33M-9.38%2M
Research and development costs 34.57%8.31M2.13%7.01M11.20%7.17M2.26%27.02M0.57%7.53M-7.49%6.17M15.30%6.87M2.25%6.45M26.49%26.42M39.22%7.49M
Operating profit -29.43%-10.73M-6.56%-9.65M-10.49%-9.31M-1.01%-36.04M-3.33%-10.27M7.11%-8.29M-10.85%-9.05M2.55%-8.42M-11.03%-35.68M-24.52%-9.94M
Net non-operating interest income expense -272.57%-2.31M-44.99%944K61.26%716K-16.60%3.93M-42.99%435K-34.09%1.34M18.75%1.72M-7.11%444K166.59%4.72M-90.42%763K
Non-operating interest income -------------11.45%4.28M----------------169.83%4.83M----
Non-operating interest expense ------------304.00%303K------------------75K----
Total other finance cost 117.57%617K63.68%748K-61.26%-716K5.13%41K-11.35%3.54M11.43%-3.51M-6.54%457K7.11%-444K85.71%39K164.63%3.99M
Other net income (expense) -79.98%365K154.01%1.82M
Gain on sale of security -------------79.98%365K----------------154.01%1.82M----
Income before tax -68.89%-11.69M-36.42%-10.05M-7.67%-8.59M-8.93%-31.74M-28.78%-9.47M-39.85%-6.92M15.01%-7.37M2.28%-7.98M13.64%-29.14M-116.83%-7.36M
Income tax -8K2,066.67%65K9,800.00%99K-62.50%6K-75.00%2K0-88.46%3K-95.24%1K-20.00%16K166.67%8K
Net income -68.78%-11.69M-37.25%-10.11M-8.90%-8.69M-8.89%-31.75M-28.66%-9.48M-40.96%-6.92M15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M
Net income continuous Operations -68.78%-11.69M-37.25%-10.11M-8.90%-8.69M-8.89%-31.75M-28.66%-9.48M-40.96%-6.92M15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M
Minority interest income
Net income attributable to the parent company -68.78%-11.69M-37.25%-10.11M-8.90%-8.69M-8.89%-31.75M-28.66%-9.48M-40.96%-6.92M15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -68.78%-11.69M-37.25%-10.11M-8.90%-8.69M-8.89%-31.75M-28.66%-9.48M-40.96%-6.92M15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M
Basic earnings per share -40.00%-0.14-18.18%-0.13-9.09%-0.12-7.14%-0.45-18.18%-0.13-42.86%-0.18.33%-0.118.33%-0.1120.75%-0.42-175.00%-0.11
Diluted earnings per share -40.00%-0.14-18.18%-0.13-9.09%-0.12-7.14%-0.45-18.18%-0.13-42.86%-0.18.33%-0.118.33%-0.1120.75%-0.42-175.00%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -